Skip to main content
. 2018 Jul 16;12:2223–2231. doi: 10.2147/DDDT.S163595

Figure 5.

Figure 5

Combined nimotuzumab and celecoxib cooperatively inhibits cytoplasmic and nuclear EGFR signaling pathways in CNE2 cell line. CNE2 cells were incubated with N50 or C25 or the combination for 48 hours. Cytoplasmic and nuclear extracts were harvested for Western blot analysis. (A) Cytoplasmic levels of EGFR, p-EGFR, p-ERK1/2, p-STAT3, p-AKT and COX-2. (B) Nuclear levels of EGFR and PCNA.